HutchMED (China) LIMITED Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
HutchMED (China) LIMITED (HCM) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$86.23 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-03-05
- HutchMED (China) LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was $4.11M.
- HutchMED (China) LIMITED cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was -$8.36M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$86.23M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | -$45.98M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | -$126.23M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | -$77.83M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | -$23.22M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | -$83.72M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | -$54.77M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $95.21M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $139.49M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $351.12M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $108.93M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | -$71.15M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $36.62M 20-F · filed 2022-03-03 | |||
| 2019-09-30 | $12.89M 6-K · filed 2020-01-21 | |||
| 2019-06-30 | -$2.42M 6-K · filed 2020-07-30 | |||
| 2019-03-31 | $4.11M 6-K · filed 2019-06-06 | |||
| 2018-12-31 | $2.67M 20-F · filed 2021-03-04 | |||
| 2018-09-30 | $32.28M 6-K · filed 2020-01-21 | |||
| 2018-06-30 | -$10.65M 6-K · filed 2019-07-30 | |||
| 2018-03-31 | -$8.36M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $3.47M 20-F · filed 2020-03-03 | |||
| 2016-12-31 | $49.27M 20-F · filed 2019-03-11 |